Every day, Volpara software helps clinicians better understand their patients and administrators better understand their practices.
Volpara listed on the ASX in April 2016. It raised A$10 million: ramp up its management & sales force, expand product offerings and offer advanced data analytics.
The company had solid early sales. In FY16, its revenue was NZ$2.5 million (up 31% pcp) with a small sales team and capital sales model. Around 90% of sales are in the US.